Cargando…

SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice

BACKGROUND AND AIMS: Diabetes is a major risk factor of atherosclerosis and its complications. The loss-of-function mutation E1506K in the sulfonylurea receptor 1 (SUR1-E1506K) induces hyperinsulinemia in infancy, leading to impaired glucose tolerance and increased risk of type 2 diabetes. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gurzeler, Erika, Ruotsalainen, Anna-Kaisa, Laine, Anssi, Valkama, Teemu, Kettunen, Sanna, Laakso, Markku, Ylä-Herttuala, Seppo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589160/ https://www.ncbi.nlm.nih.gov/pubmed/34767557 http://dx.doi.org/10.1371/journal.pone.0258408

Ejemplares similares

Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice
por: Theelen, Thomas L., et al.
Publicado: (2015)

Nucleic Acid–Based Therapies for Atherosclerosis
por: Mäkinen, Petri, et al.
Publicado: (2020)

Novel RNAi-Based Therapies for Atherosclerosis
por: Ruotsalainen, Anna-Kaisa, et al.
Publicado: (2021)

Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity
por: Kettunen, Sanna, et al.
Publicado: (2023)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

Lipidome of Atherosclerotic Plaques from Hypercholesterolemic Rabbits
por: Bojic, Lazar A., et al.
Publicado: (2014)

In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR(–/–)ApoB(100/100) mice
por: Blanco, Fabiana, et al.
Publicado: (2018)

Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance T(RAFFn), T(1ρ) and T(2) relaxation times
por: Ylä-Herttuala, Elias, et al.
Publicado: (2023)

A Mouse Model of Human Hyperinsulinism Produced by the E1506K Mutation in the Sulphonylurea Receptor SUR1
por: Shimomura, Kenju, et al.
Publicado: (2013)

Amyloid-Targeting PET Tracer [(18)F]Flutemetamol Accumulates in Atherosclerotic Plaques
por: Hellberg, Sanna, et al.
Publicado: (2019)

Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells
por: Mallick, Rahul, et al.
Publicado: (2022)

Epigenetic Regulation of Vascular Smooth Muscle Cell Phenotype Switching in Atherosclerotic Artery Remodeling: A Mini-Review
por: Zurek, Michelle, et al.
Publicado: (2021)

Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques
por: Silvola, Johanna M. U., et al.
Publicado: (2016)

Capitulaciones colombinas (1492-1506) /
por: Fernández, Rafael Diego
Publicado: (1987)

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits
por: Yu, Qing-qing, et al.
Publicado: (2019)

Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice
por: Weisell, Jonna, et al.
Publicado: (2021)

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
por: Depuydt, Marie A.C., et al.
Publicado: (2020)

Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye
por: Koponen, Sanna, et al.
Publicado: (2021)

1506. Outcomes of Standardized Neonatal Cephalexin Dosing
por: Robertson, Melena J, et al.
Publicado: (2019)

Left ventricular remodeling leads to heart failure in mice with cardiac‐specific overexpression of VEGF‐B(167): echocardiography and magnetic resonance imaging study
por: Lottonen‐Raikaslehto, Line, et al.
Publicado: (2017)

Oxidized Phospholipids are Proinflammatory and Proatherogenic in Hypercholesterolemic Mice
por: Que, Xuchu, et al.
Publicado: (2018)

Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography
por: Silvola, Johanna M. U., et al.
Publicado: (2018)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
por: Merentie, Mari, et al.
Publicado: (2018)

Vascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart
por: Naumenko, Nikolay, et al.
Publicado: (2017)

Gene Therapy Used in Cancer Treatment
por: Wirth, Thomas, et al.
Publicado: (2014)

Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?
por: Mallick, Rahul, et al.
Publicado: (2022)

Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice
por: Heinonen, Suvi E, et al.
Publicado: (2011)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine
por: Brinkmann, Saskia J. H., et al.
Publicado: (2015)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
por: Kivelä, A. M., et al.
Publicado: (2017)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k7hc9901l7p4mqaq8iif8mvfe0